Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

Thoracic Aortic Aneurysms Clinical Trial

Official title:
Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft in Patients With Thoracic Aortic Pathologies

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of the Relay thoracic stent-graft system to treat thoracic aortic aneurysms. Efficacy will be evaluated by the device-related adverse event rate of endovascular repair (via Relay Thoracic Stent-Graft) through 1-year. Safety will be evaluated by comparing major adverse events through 1-year in subjects treated with the Relay Thoracic Stent-Graft to those who underwent surgical repair. Long term follow-up is conducted through 5 years.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00435942
Study type	Interventional
Source	Bolton Medical
Contact
Status	Completed
Phase	N/A
Start date	January 2007
Completion date	May 15, 2017

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT00583817` - Endovascular Treatment of Thoracic Aortic Disease	N/A
Completed	`NCT00597870` - Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions	N/A
Completed	`NCT00604799` - VALOR: The Talent Thoracic Stent Graft System Clinical Study	Phase 2/Phase 3
Recruiting	`NCT03142074` - Biomechanical and Microstructural Properties of Ascending Aortic Aneurysms
Completed	`NCT01839695` - Safety and Efficacy of Valiant Mona LSA Stent Graft System	N/A
Terminated	`NCT00805948` - Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)	N/A